Plagued by low sales of its genetic tests, 23andMe adopts a bold new plan: slash prices and enter the pharmaceutical industry. But with investors nervous, can CEO Anne Wojcicki keep the show going long enough to make her DNA dream pay off?Be the first to know about Wondery’s newest podcasts, curated recommendations, and more! Sign up now at <a href="https://wondery.fm/wonderynewsletter" rel="noopener noreferrer" target="_blank">https://wondery.fm/wonderynewsletter</a>Listen to Business Wars on the Wondery App or wherever you get your podcasts. Experience all episodes ad-free and be the first to binge the newest season. Unlock exclusive early access by joining Wondery+ in the Wondery App or on Apple Podcasts. Start your free trial today by visiting <a href="http://wondery.com/links/business-wars/" rel="noopener noreferrer" target="_blank">wondery.com/links/business-wars/</a> now.See Privacy Policy at <a href="https://art19.com/privacy" rel="noopener noreferrer" target="_blank">https://art19.com/privacy</a> and California Privacy Notice at <a href="https://art19.com/privacy#do-not-sell-my-info" rel="noopener noreferrer" target="_blank">https://art19.com/privacy#do-not-sell-my-info</a>.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

23andMe's Fatal Flaw | Defying Gravity? | 2

Business Wars

AI Chapters

AI Insights

Reviews